Mobile and video technology research and development company InterDigital, Inc (NASDAQ:IDCC) boosted its third-quarter 2022 revenue outlook to $112 million – $115…
Gainers
LogicBio Therapeutics, Inc. (NASDAQ: LOGC) gained 641% to $2.0207 after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per share.
On CNBC’s "Mad Money Lightning Round," Jim Cramer said UiPath Inc (NASDAQ: PATH) is losing money, and he is not recommending companies that are losing money.
Most FDA decisions scheduled for September yielded positive results, but there were stray disappointments as well. Seven new molecular entities, or NMEs, were approved during the month, taking the total NME approvals for the year to 24. This is far less than the 40 approvals received by the same time last year.
Electric vehicle stocks moved to the downside once again in the week that ended Sept. 30 as economic worries continue to roil the broader market. Lordstown Motors Corp. (NASDAQ: RIDE) and Workhorse Group, Inc.